Literature DB >> 22798686

Type II NKT cells facilitate Alum-sensing and humoral immunity.

Hemangi B Shah1, T Scott Devera, Pragya Rampuria, Gillian A Lang, Mark L Lang.   

Abstract

Alum-based adjuvants facilitate vaccine-driven humoral immunity, but their mechanism of action remains poorly understood. Herein, we report that lack of type II NKT cells is associated with intact, mature B cells but dampened humoral immunity following immunization with Alum-adsorbed T-dependent antigen. Type II NKT cells facilitated production of IL-4, IL-5, IL-10, IL-13, and antibody by LN and splenocyte cultures following Alum/antigen administration in vivo and antigen restimulation in vitro. Addition of IL-4 and IL-5 to type II NKT-deficient cultures restored in vitro antibody production. Intracellular staining revealed that Alum-primed type II NKT cells coordinated IL-4 secretion by T cells. Alum did not significantly affect CD1d expression in vivo, but addition of CD1d-blocking mAb diminished cytokine production and in vitro antibody production. Type II NKT cells therefore function as part of the Alum-sensing apparatus and in a CD1d-dependent manner, facilitate T(H)2-driven humoral immunity. This may have important consequences for understanding the mechanism of action of Alum-containing vaccines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22798686      PMCID: PMC3441316          DOI: 10.1189/jlb.0412177

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  41 in total

1.  Invariant NKT cells sustain specific B cell responses and memory.

Authors:  Grazia Galli; Paola Pittoni; Elena Tonti; Carmine Malzone; Yasushi Uematsu; Marco Tortoli; Domenico Maione; Gianfranco Volpini; Oretta Finco; Sandra Nuti; Simona Tavarini; Paolo Dellabona; Rino Rappuoli; Giulia Casorati; Sergio Abrignani
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-27       Impact factor: 11.205

Review 2.  How dying cells alert the immune system to danger.

Authors:  Hajime Kono; Kenneth L Rock
Journal:  Nat Rev Immunol       Date:  2008-03-14       Impact factor: 53.106

3.  Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

Authors:  J Cui; T Shin; T Kawano; H Sato; E Kondo; I Toura; Y Kaneko; H Koseki; M Kanno; M Taniguchi
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

4.  DNA released from dying host cells mediates aluminum adjuvant activity.

Authors:  Thomas Marichal; Keiichi Ohata; Denis Bedoret; Claire Mesnil; Catherine Sabatel; Kouji Kobiyama; Pierre Lekeux; Cevayir Coban; Shizuo Akira; Ken J Ishii; Fabrice Bureau; Christophe J Desmet
Journal:  Nat Med       Date:  2011-07-17       Impact factor: 53.440

5.  Glycolipid-activated NKT cells support the induction of persistent plasma cell responses and antibody titers.

Authors:  T Scott Devera; Hemangi B Shah; Gillian A Lang; Mark L Lang
Journal:  Eur J Immunol       Date:  2008-04       Impact factor: 5.532

6.  The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity.

Authors:  Marshall D Behrens; Wolfgang M Wagner; Christopher J Krco; Courtney L Erskine; Kimberly R Kalli; James Krempski; Ekram A Gad; Mary L Disis; Keith L Knutson
Journal:  Blood       Date:  2007-11-20       Impact factor: 22.113

7.  Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis.

Authors:  Elena Ambrosino; Masaki Terabe; Ramesh C Halder; Judy Peng; Shun Takaku; Sachiko Miyake; Takashi Yamamura; Vipin Kumar; Jay A Berzofsky
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

8.  Pivotal advance: eosinophils mediate early alum adjuvant-elicited B cell priming and IgM production.

Authors:  Hai-Bin Wang; Peter F Weller
Journal:  J Leukoc Biol       Date:  2008-01-11       Impact factor: 4.962

9.  Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments.

Authors:  Y H Chiu; J Jayawardena; A Weiss; D Lee; S H Park; A Dautry-Varsat; A Bendelac
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

10.  Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells.

Authors:  Mirjam Kool; Thomas Soullié; Menno van Nimwegen; Monique A M Willart; Femke Muskens; Steffen Jung; Henk C Hoogsteden; Hamida Hammad; Bart N Lambrecht
Journal:  J Exp Med       Date:  2008-03-24       Impact factor: 14.307

View more
  14 in total

Review 1.  Key roles of adjuvants in modern vaccines.

Authors:  Steven G Reed; Mark T Orr; Christopher B Fox
Journal:  Nat Med       Date:  2013-12-05       Impact factor: 53.440

2.  Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.

Authors:  Igor Maricic; Enrico Girardi; Dirk M Zajonc; Vipin Kumar
Journal:  J Immunol       Date:  2014-09-26       Impact factor: 5.422

Review 3.  Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.

Authors:  Suryasarathi Dasgupta; Vipin Kumar
Journal:  Immunogenetics       Date:  2016-07-12       Impact factor: 2.846

4.  DOCK8 is essential for LFA-1-dependent positioning of T follicular helper cells in germinal centers.

Authors:  Erin Janssen; Mira Tohme; Jordan Butts; Sophie Giguere; Peter T Sage; Francisco E Velázquez; Christy Kam; Elena Milin; Mrinmoy Das; Ali Sobh; Salem Al-Tamemi; Francis W Luscinskas; Facundo Batista; Raif S Geha
Journal:  JCI Insight       Date:  2020-08-06

Review 5.  Type II NKT Cells and Their Emerging Role in Health and Disease.

Authors:  Madhav V Dhodapkar; Vipin Kumar
Journal:  J Immunol       Date:  2017-02-01       Impact factor: 5.422

6.  CD1d-dependent expansion of NKT follicular helper cells in vivo and in vitro is a product of cellular proliferation and differentiation.

Authors:  Pragya Rampuria; Mark L Lang
Journal:  Int Immunol       Date:  2015-02-20       Impact factor: 4.823

7.  Critical role of NKT cells in posttransplant alloantibody production.

Authors:  J M Zimmerer; P Swamy; P B Sanghavi; C L Wright; M Abdel-Rasoul; S M Elzein; R R Brutkiewicz; G L Bumgardner
Journal:  Am J Transplant       Date:  2014-09-12       Impact factor: 8.086

8.  Type II NKT Cell Agonist, Sulfatide, Is an Effective Adjuvant for Oral Heat-Killed Cholera Vaccines.

Authors:  Aqel Albutti; Stephanie Longet; Craig P McEntee; Shauna Quinn; Alex Liddicoat; Cristiana Rîmniceanu; Nils Lycke; Lydia Lynch; Susanna Cardell; Ed C Lavelle
Journal:  Vaccines (Basel)       Date:  2021-06-08

9.  Alum Directly Modulates Murine B Lymphocytes to Produce IgG1 Isotype.

Authors:  Bo-Ra Jin; Sun-Jin Kim; Jeong-Min Lee; Seong-Ho Kang; Hye-Ju Han; Young-Saeng Jang; Goo-Young Seo; Pyeung-Hyeun Kim
Journal:  Immune Netw       Date:  2013-02-28       Impact factor: 6.303

Review 10.  Particulate adjuvant and innate immunity: past achievements, present findings, and future prospects.

Authors:  Etsushi Kuroda; Cevayir Coban; Ken J Ishii
Journal:  Int Rev Immunol       Date:  2013-04       Impact factor: 5.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.